Ceftriaxone attenuates hypoxic-ischemic brain injury in neonatal rats

Journal of Biomedical Science

Volumn 18, Issue 1, 2011, Pages

  Lai, Pei ^a,b   Huang, Yen ^a,b   Wu, Chia ^b   Lai, Ching Jung ^a   Wang, Pen ^b   Chiu, Ted H ^a  

^a TZU CHI UNIVERSITY   (Taiwan)

^b BUDDHIST TZU CHI GENERAL HOSPITAL   (Taiwan)

Author keywords

lactam antibiotics; ceftriaxone; EAAT2; GLT1; hypoxic ischemic injury; neonatal rat

Indexed keywords

CEFTRIAXONE; GLUCOSE TRANSPORTER 1; EXCITATORY AMINO ACID TRANSPORTER 2; GLUTAMIC ACID;

AMNESIA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BRAIN CORTEX; BRAIN NERVE CELL; BRAIN TISSUE; CAROTID ARTERY LIGATION; CONTROLLED STUDY; FEMALE; HIPPOCAMPUS; HISTOPATHOLOGY; HYPOXIC ISCHEMIC ENCEPHALOPATHY; IMMUNOHISTOCHEMISTRY; INJURY SEVERITY; LEARNING DISORDER; MALE; MYELINATION; NERVE CELL LESION; NEUROPATHOLOGY; NEUROPROTECTION; NEWBORN; NICK END LABELING; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; WESTERN BLOTTING; WHITE MATTER; ANIMAL; ASTROCYTE; CYTOLOGY; DRUG EFFECT; GENE EXPRESSION REGULATION; METABOLISM; NEUROPSYCHOLOGICAL TEST;

RATTUS;

ANIMALS; ANIMALS, NEWBORN; ASTROCYTES; BLOTTING, WESTERN; CEFTRIAXONE; EXCITATORY AMINO ACID TRANSPORTER 2; GENE EXPRESSION REGULATION; GLUTAMIC ACID; HIPPOCAMPUS; HYPOXIA-ISCHEMIA, BRAIN; IMMUNOHISTOCHEMISTRY; IN SITU NICK-END LABELING; NEUROPSYCHOLOGICAL TESTS; RATS;

EID: 80053173773     PISSN: 10217770     EISSN: 14230127     Source Type: Journal    
DOI: 10.1186/1423-0127-18-69     Document Type: Article

References (53)

1. Long-term pharmacologic neuroprotection after birth asphyxia: where do we stand? van Bel F, Groenendaal F, Neonatology 2008 94 203 210 10.1159/000143723 18832856
2. Long-term cognitive and behavioral consequences of neonatal encephalopathy following perinatal asphyxia: a review. van Handel M, Swaab H, de Vries LS, Jongmans MJ, Eur J Pediatr 2007 166 645 654 10.1007/s00431-007-0437-8 17426984 (Pubitemid 46800741)
3. Intervention strategies for neonatal hypoxic-ischemic cerebral injury. Perlman JM, Clin Ther 2006 28 1353 1365 10.1016/j.clinthera.2006.09.005 17062309 (Pubitemid 44740075)
4. Rat model of perinatal hypoxic-ischemic brain damage. Vannucci RC, Connor JR, Mauger DT, Palmer C, Smith MB, Towfighi J, Vannucci SJ, J Neurosci Res 1999 55 158 163 10.1002/(SICI)1097-4547(19990115)55:2<158::AID-JNR3>3.0.CO;2-1 9972818 (Pubitemid 29056956)
5. Improved survival rates with increased neurodevelopmental disability for extremely low birth weight infants in the 1990s. Wilson-Costello D, Friedman H, Minich N, Fanaroff AA, Hack M, Pediatrics 2005 115 997 1003 10.1542/peds.2004- 0221 15805376
6. Neurological outcomes at 18 months of age after moderate hypothermia for perinatal hypoxic ischaemic encephalopathy: synthesis and meta-analysis of trial data. Edwards AD, Brocklehurst P, Gunn AJ, Halliday H, Juszczak E, Levene M, Strohm B, Thoresen M, Whitelaw A, Azzopardi D, BMJ 2010 340 363 369 10.1136/bmj.c363 20144981
7. Functional comparisons of three glutamate transporter subtypes cloned from human motor cortex. Arriza JL, Fairman WA, Wadiche JI, Murdoch GH, Kavanaugh MP, Amara SG, J Neurosci 1994 14 5559 5569 7521911 (Pubitemid 24279072)
8. Molecular pharmacology of glutamate transporters, EAATs and VGLUTs. Shigeri Y, Seal RP, Shimamoto K, Brain Res Brain Res Rev 2004 45 250 265 15210307 (Pubitemid 38802874)
9. Antisense knockdown of the glial glutamate transporter GLT-1, but not the neuronal glutamate transporter EAAC1, exacerbates transient focal cerebral ischemia-induced neuronal damage in rat brain. Rao VL, Dogan A, Todd KG, Bowen KK, Kim BT, Rothstein JD, Dempsey RJ, J Neurosci 2001 1 1876 1883 (Pubitemid 32221371)
10. Knockout of glutamate transporters reveals a major role for astroglial transport in excitotoxicity and clearance of glutamate. Rothstein JD, Dykes-Hoberg M, Pardo CA, Bristol LA, Jin L, Kuncl RW, Kanai Y, Hediger MA, Wang Y, Schielke JP, Welty DF, Neuron 1996 16 675 686 10.1016/S0896-6273(00)80086-0 8785064 (Pubitemid 26103145)
11. Selective loss of glial glutamate transporter GLT-1 in amyotrophic lateral sclerosis. Rothstein JD, Van Kammen M, Levey AI, Martin LJ, Kuncl RW, Ann Neurol 1995 38 73 84 10.1002/ana.410380114 7611729
12. Glutamate transporter alterations in Alzheimer disease are possibly associated with abnormal APP expression. Li S, Mallory M, Alford M, Tanaka S, Masliah E, J Neuropathol Exp Neurol 1997 56 901 911 10.1097/00005072-199708000- 00008 9258260 (Pubitemid 27329111)
13. Changes of NMDA receptor subunit (NR1, NR2B) and glutamate transporter (GLT1) mRNA expression in Huntington's disease - an in situ hybridization study. Arzberger T, Krampfl K, Leimgruber S, Weindl A, J Neuropathol Exp Neurol 1997 56 440 454 10.1097/00005072-199704000-00013 9100675 (Pubitemid 27465027)
14. Beta-lactam antibiotics offer neuroprotection by increasing glutamate transporter expression. Rothstein JD, Patel S, Regan MR, Haenggeli C, Huang YH, Bergles DE, Jin L, Dykes Hoberg M, Vidensky S, Chung DS, Toan SV, Bruijn LI, Su ZZ, Gupta P, Fisher PB, Nature 2005 433 73 77 10.1038/nature03180 15635412 (Pubitemid 40101145)
15. The role of glutamate transporters in neurodegenerative diseases and potential opportunities for intervention. Sheldon AL, Robinson MB, Neurochem Int 2007 51 333 355 10.1016/j.neuint.2007.03.012 17517448 (Pubitemid 47503456)
16. Neuroprotective potential of ceftriaxone in in vitro models of stroke. Lipski J, Wan CK, Bai JZ, Pi R, Li D, Donnelly D, Neuroscience 2007 146 617 629 10.1016/j.neuroscience.2007.02.003 17363173 (Pubitemid 46617069)
17. The beta-lactam antibiotic, ceftriaxone, dramatically improves survival, increases glutamate uptake and induces neurotrophins in stroke. Thone-Reineke C, Neumann C, Namsolleck P, Schmerbach K, Krikov M, Schefe JH, Lucht K, Hortnagl H, Godes M, Muller S, Rumschussel K, Funke-Kaiser H, Villringer A, Steckelings UM, Unger T, J Hypertens 2008 26 2426 2435 10.1097/HJH.0b013e328313e403 19008722
18. Hypoxia-ischaemia model in the 7-day-old rat: possibilities and shortcomings. Hagberg H, Bona E, Gilland E, Puka-Sundvall M, Acta Paediatr 1997 422 Suppl 85 88 (Pubitemid 27345471)
19. 17beta-estradiol protects the neonatal brain from hypoxia-ischemia. Nunez J, Yang Z, Jiang Y, Grandys T, Mark I, Levison SW, Exp Neurol 2007 208 269 276 10.1016/j.expneurol.2007.08.020 17950281 (Pubitemid 350101505)
20. The influence of immaturity on hypoxic-ischemic brain damage in the rat. Rice JE, Vannucci RC, Brierley JB, Ann Neurol 1981 9 131 141 10.1002/ana.410090206 7235629 (Pubitemid 11191192)
21. George Paxinos CW, The rat brain in stereotaxis of coordinates Orlando, Florida, Academic press 1986
22. Strain-related brain injury in neonatal mice subjected to hypoxia-ischemia. Sheldon RA, Sedik C, Ferriero DM, Brain Res 1998 810 114 122 10.1016/S0006-8993(98)00892-0 9813271 (Pubitemid 29003396)
23. Hypoxia-ischemia induced neurological dysfunction and brain injury in the neonatal rat. Fan LW, Lin S, Pang Y, Lei M, Zhang F, Rhodes PG, Cai Z, Behav Brain Res 2005 165 80 90 10.1016/j.bbr.2005.06.033 16140403 (Pubitemid 41476207)
24. Neurological reflexes and early motor behavior in rats subjected to neonatal hypoxic-ischemic injury. Lubics A, Reglodi D, Tamas A, Kiss P, Szalai M, Szalontay L, Lengvari I, Behav Brain Res 2005 157 157 165 10.1016/j.bbr.2004.06.019 15617782 (Pubitemid 40029710)
25. Glutamate receptor-mediated oligodendrocyte toxicity in periventricular leukomalacia: a protective role for topiramate. Follett PL, Deng W, Dai W, Talos DM, Massillon LJ, Rosenberg PA, Volpe JJ, Jensen FE, J Neurosci 2004 24 4412 4420 10.1523/JNEUROSCI.0477-04.2004 15128855 (Pubitemid 38608152)
26. Cell death in perinatal hypoxic-ischaemic brain injury. Scott RJ, Hegyi L, Neuropathol Appl Neurobiol 1997 23 307 314 10.1111/j.1365-2990.1997.tb01300.x 9292869 (Pubitemid 27352841)
27. Pharmacological induction of ischemic tolerance by glutamate transporter-1 (EAAT2) upregulation. Chu K, Lee ST, Sinn DI, Ko SY, Kim EH, Kim JM, Kim SJ, Park DK, Jung KH, Song EC, Lee SK, Kim M, Roh JK, Stroke 2007 38 177 182 17122424 (Pubitemid 46035624)
28. Neurobiology of hypoxic-ischemic injury in the developing brain. Johnston MV, Trescher WH, Ishida A, Nakajima W, Pediatr Res 2001 49 735 741 10.1203/00006450-200106000-00003 11385130 (Pubitemid 32522044)
29. NMDA receptors mediate calcium accumulation in myelin during chemical ischaemia. Micu I, Jiang Q, Coderre E, Ridsdale A, Zhang L, Woulfe J, Yin X, Trapp BD, McRory JE, Rehak R, Zamponi GW, Wang W, Stys PK, Nature 2006 439 988 992 16372019 (Pubitemid 43292418)
30. A role for glutamate and its receptors in the regulation of oligodendrocyte development in cerebellar tissue slices. Yuan X, Eisen AM, McBain CJ, Gallo V, Development 1998 25 2901 2914 (Pubitemid 28410214)
31. NBQX attenuates excitotoxic injury in developing white matter. Follett PL, Rosenberg PA, Volpe JJ, Jensen FE, J Neurosci 2000 20 9235 9241 11125001 (Pubitemid 32042926)
32. NMDA receptor blockade with memantine attenuates white matter injury in a rat model of periventricular leukomalacia. Manning SM, Talos DM, Zhou C, Selip DB, Park HK, Park CJ, Volpe JJ, Jensen FE, J Neurosci 2008 28 6670 6678 10.1523/JNEUROSCI.1702-08.2008 18579741
33. The excitatory amino acid antagonist kynurenic acid administered after hypoxic-ischemia in neonatal rats offers neuroprotection. Andine P, Lehmann A, Ellren K, Wennberg E, Kjellmer I, Nielsen T, Hagberg H, Neurosci Lett 1988 90 208 212 10.1016/0304-3940(88)90813-0 3412643
34. MK-801 prevents hippocampal neurodegeneration in neonatal hypoxic-ischemic rats. Ford LM, Sanberg PR, Norman AB, Fogelson MH, Arch Neurol 1989 46 1090 1096 2552968 (Pubitemid 19246298)
35. Hypoxia-ischemia in the neonatal rat brain: histopathology after post-treatment with NMDA and non-NMDA receptor antagonists. Hagberg H, Gilland E, Diemer NH, Andine P, Biol Neonate 1994 66 205 213 10.1159/000244109 7865635 (Pubitemid 24361031)
36. MK-801 protects the neonatal brain from hypoxic-ischemic damage. McDonald JW, Silverstein FS, Johnston MV, Eur J Pharmacol 1987 140 359 361 10.1016/0014-2999(87)90295-0 2820765 (Pubitemid 17145361)
37. Distribution of glutamate transporter subtypes during human brain development. Bar-Peled O, Ben-Hur H, Biegon A, Groner Y, Dewhurst S, Furuta A, Rothstein JD, J Neurochem 1997 69 2571 2580 9375691 (Pubitemid 27495445)
38. Glutamate transporter EAAT2 expression is up-regulated in reactive astrocytes in human periventricular leukomalacia. Desilva TM, Billiards SS, Borenstein NS, Trachtenberg FL, Volpe JJ, Kinney HC, Rosenberg PA, J Comp Neurol 2008 508 238 248 10.1002/cne.21667 18314905 (Pubitemid 351562035)
39. The glutamate transporter EAAT2 is transiently expressed in developing human cerebral white matter. Desilva TM, Kinney HC, Borenstein NS, Trachtenberg FL, Irwin N, Volpe JJ, Rosenberg PA, J Comp Neurol 2007 501 879 890 10.1002/cne.21289 17311320 (Pubitemid 46797137)
40. Glutamate transporter protein subtypes are expressed differentially during rat CNS development. Furuta A, Rothstein JD, Martin LJ, J Neurosci 1997 17 8363 8375 9334410 (Pubitemid 27461059)
41. Developmental expression of glutamate transporters and glutamate dehydrogenase in astrocytes of the postnatal rat hippocampus. Kugler P, Schleyer V, Hippocampus 2004 14 975 985 10.1002/hipo.20015 15390174 (Pubitemid 40073658)
42. Altered expressions of glutamate transporter subtypes in rat model of neonatal cerebral hypoxia-ischemia. Fukamachi S, Furuta A, Ikeda T, Ikenoue T, Kaneoka T, Rothstein JD, Iwaki T, Brain Res Dev Brain Res 2001 132 131 139 11744117 (Pubitemid 34024955)
43. Hypoxia suppresses glutamate transport in astrocytes. Dallas M, Boycott HE, Atkinson L, Miller A, Boyle JP, Pearson HA, Peers C, J Neurosci 2007 27 3946 3955 10.1523/JNEUROSCI.5030-06.2007 17428968 (Pubitemid 46597168)
44. The release and uptake of excitatory amino acids. Nicholls D, Attwell D, Trends Pharmacol Sci 1990 11 462 468 10.1016/0165-6147(90)90129-V 1980041 (Pubitemid 20351933)
45. Selective dysfunction of hippocampal CA1 astrocytes contributes to delayed neuronal damage after transient forebrain ischemia. Ouyang YB, Voloboueva LA, Xu LJ, Giffard RG, J Neurosci 2007 27 4253 4260 10.1523/JNEUROSCI.0211-07.2007 17442809 (Pubitemid 46640722)
46. A beta-lactam antibiotic dampens excitotoxic inflammatory CNS damage in a mouse model of multiple sclerosis. Melzer N, Meuth SG, Torres-Salazar D, Bittner S, Zozulya AL, Weidenfeller C, Kotsiari A, Stangel M, Fahlke C, Wiendl H, PLoS One 2008 3 3149 3160 10.1371/journal.pone.0003149 18773080
47. Glutamate uptake. Danbolt NC, Prog Neurobiol 2001 65 1 105 10.1016/S0301-0082(00)00067-8 11369436 (Pubitemid 32479155)
48. Expression of a variant form of the glutamate transporter GLT1 in neuronal cultures and in neurons and astrocytes in the rat brain. Chen W, Aoki C, Mahadomrongkul V, Gruber CE, Wang GJ, Blitzblau R, Irwin N, Rosenberg PA, J Neurosci 2002 22 2142 2152 11896154 (Pubitemid 35386514)
49. A quantitative assessment of glutamate uptake into hippocampal synaptic terminals and astrocytes: new insights into a neuronal role for excitatory amino acid transporter 2 (EAAT2). Furness DN, Dehnes Y, Akhtar AQ, Rossi DJ, Hamann M, Grutle NJ, Gundersen V, Holmseth S, Lehre KP, Ullensvang K, Wojewodzic M, Zhou Y, Attwell D, Danbolt NC, Neuroscience 2008 157 80 94 10.1016/j. neuroscience.2008.08.043 18805467
50. The concentrations and distributions of three C-terminal variants of the GLT1 (EAAT2; slc1a2) glutamate transporter protein in rat brain tissue suggest differential regulation. Holmseth S, Scott HA, Real K, Lehre KP, Leergaard TB, Bjaalie JG, Danbolt NC, Neuroscience 2009 162 1055 1071 10.1016/j.neuroscience. 2009.03.048 19328838
51. Long-term effects of neonatal ischemic-hypoxic brain injury on sensorimotor and locomotor tasks in rats. Jansen EM, Low WC, Behav Brain Res 1996 78 189 194 10.1016/0166-4328(95)00248-0 8864051 (Pubitemid 26252888)
52. Antibiotic selection in obstetric patients. Duff P, Infect Dis Clin North Am 1997 11 1 12 10.1016/S0891-5520(05)70338-X 9067781 (Pubitemid 27182267)
53. Clinical pharmacokinetics of ceftriaxone during the third trimester of pregnancy and study of its transplacental passage in two patients. Bourget P, Quinquis V, Fernandez H, Frydman R, Pathol Biol (Paris) 1993 41 242 248 (Pubitemid 23166395)